Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)

Clinical trial NCT01773278 · UNKNOWN

Trial details

NCT number: NCT01773278
Sponsor: University of Colorado, Denver
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Smith-Lemli-Opitz Syndrome Cone-Rod Dystrophy Hearing Loss

Start date: 2008-12-01
Primary completion: 2025-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.